Skip to search formSkip to main contentSkip to account menu

MK 0991

Known as: MK-0991 
National Institutes of Health

Related topics

Related topics

4 relations
CancidasL-743,873

Broader (2)

CaspofunginCaspofungin acetate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
La caspofungine, une nouvelle arme dans le traitement des aspergilloses invasives
La caspofungine (MK-0991 ; L-743,872 ; CASPOFUNGIN MSD®) appartient a la famille des echinocandines, une nouvelle classe d… 
2004
2004
Effects of caspofungin (MK-0991) and anidulafungin (LY303366) on phagocytosis, oxidative burst and killing of Candida albicans by human phagocytes
The objective of the present study was to investigate the influence of the new echinocandins caspofungin (MK-0991) and… 
2003
2003
A new antifungal sterol sulfate, Sch 601324, from Chrysosporium sp.
synthase have been discovered, including lipopeptides (pneumocandins and echinocandins), glycolipids (papulacandins) and… 
2001
2001
Determination of an echinocandin, MK-0991, in mammalian plasma by radioimmunoassay.
2000
2000
Influence of Human Sera on the In Vitro Activity of the Echinocandin Caspofungin (MK-0991) against Aspergillus fumigatus
ABSTRACT There have been several reports that the activity of echinocandin antifungal agents is not affected or decreased in the… 
Review
2000
Review
2000
[Invasive fungal infections. Epidemiology and new therapies].
RISING INCIDENCE: In the past two decades, systemic fungal infections, essentially invasive candidiasis, but also invasive… 
1999
1999
MK-0991 (Merck & Co).
  • A. GrollT. Walsh
  • IDrugs : the investigational drugs journal
  • 1999
  • Corpus ID: 25325816
Merck is developing the echinocandin-type antifungal, MK-0991 (L-743872), a beta-1,3-glucan synthesis inhibitor. It is currently… 
1999
1999
Antifungal drug discovery and development--fourth international summit. 10-11 March 1999, Princeton, New Jersey, USA.
  • N. Ryder
  • IDrugs : the investigational drugs journal
  • 1999
  • Corpus ID: 35983306
Genetic and genomic approaches to discovery, selection and evaluation of antifungal targets were extensively discussed by several… 
1998
1998
Novel Enzyme-Linked Immunoassay To Determine Nanogram Levels of Pneumocandins in Human Plasma
ABSTRACT A binding enzyme-linked immunosorbent assay (ELISA) has been developed for measuring nanogram concentrations of… 
1997
1997
Galgiani species and Cryptococcus neoformans . MK-0991 , and fluconazole against Candida echinocandin LY 303366 , the pneumocandin Comparison of the in vitro activities of the
species and Cryptococcus neoformans. 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)